Microbiology remains an essential tool for the detection of microorganisms present in biopharmaceutical and pharmaceutical batches.
In recent years, the industry's interest in
microbiology has grown, this has been in part due to the growing resistance of certain bacteria to antibiotics, as well as the introduction of new technologies and automated solutions which provide more rapid results for faster clinical decisions -- making the most relevant information easily accessible to clinicians, significantly improving the operational efficiency of laboratories. Microbiological considerations continue to be one of the largest areas of investment from the pharmaceutical industry.
This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and minimisation of operator intervention, to the latest technologies in rapid microbiological testing methods and data integrity.
Benefits of Attending
- DISCOVER case studies in establishing holistic Contamination Control Strategies and Real-Time Viable Air Particle Counting with leaders in the pharmaceutical industry
- GAIN insight the current state of Endotoxin testing, including alternative test methods and strategic approaches to method validation
- EXPLORE the best practice in data integrity and the automation of environmental monitoring in the Microbiology Quality Control Lab
- JOIN the important panel discussion on diversity and inclusion in the workplace with an experienced line-up of life science speakers
- DISCUSS the latest developments in the detailed, rapid detection of microbes in pharmaceutical water
Who should attend
- Heads of Aseptic Processing
- Heads of Microbiology
- Global Quality Directors
- Heads of GMP Compliance
- Quality & Compliance Heads
- Microbiology Senior Specialists
- Directors of Quality Control Biology
- Quality Control Managers
- Quality Assurance Managers
- Lean Managers
- Operations Managers
- Heads of Site Compliance
- Heads of Sterile Technology
- Global Microbiology Analytical Experts
- Cleanroom Managers
- Regulatory Affairs Managers
- Production Managers
- Quality Systems Managers
Speakers
- Andrew Davies, Microgenetics Managing Director, Microgenetics Ltd
- Benoit Ramond, Head of Microbiology & Sterile Technology, Sanofi
- Conor Murray, Principal Consultant, 3dimension Cleanrooms Limited
- David Collins, Global Technical Consultant, Ecolab Life Sciences
- Di Morris, Clinical Auditor, AstraZeneca
- Ingo Spreitzer, Deputy Head, Section 1/3 Microbiological Safety, Paul Ehrlich Institut
- James L. Drinkwater, Head of GMP compliance and Aseptic Processing support, F Ziel GmbH and PHSS
- Jim Polarine, Senior Technical Service Manager, Head of Microbiology & Sterile Technology, STERIS Corporation
- Johannes Oberdoerfer, Scientist of Rapid Microbiology Methods, Boehringer Ingelheim Pharma GmbH & Co. KG
- Karen Capper, UK Site Microbiologist, AstraZeneca
- Martin Mullner, Senior Quality Assurance Manager, Boehringer Ingelheim Pharma GmbH & Co. KG
- Peter Annel, Principal Scientist, Novo Nordisk A/S
- Pratixa Patel, Senior Director, Microbiological and Stability Sciences, GSK
- Ren-Yo Forng, Scientific Director, Amgen
- Shabnam Solati, CEO, CTL-MAT, LLC
- Stephen Smith, Global Pharma Consultant, Novatek Europe
- Suzanne Nutter, QA Group Manager, AstraZeneca
- Sven Deutschmann, Head of Global ASAT, Global QC, Roche Diagnostics GmbH
- Thierry Bonnevay, Microbiological Analytical Expert, Sanofi Pasteur
Please fill in your name and email to receive the Virtual Conference Agenda of this event.
All Timings are GMT
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
